tradingkey.logo
tradingkey.logo
Search

ImmuCell Corp

ICCC
Add to Watchlist
9.990USD
0.0000.00%
Market hours 09/22, 12:24ET
90.41MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+3.95%

1 Month

-0.70%

6 Months

+55.85%

Year to Date

+62.44%

1 Year

+61.13%

Key Figures

9.970Open
10.070High
0.00Volume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
9.990Prev. Close
9.850Low
0.00Turnover
LossP/E Static
2.84P/B
0.00%Div Yield TTM
-1.22%ROA
12.10052wk High
0.21Volume Ratio
-2.16MNet Profit
9.05MShares
-0.0617EPS TTM
0.54Beta
-1.88%ROE
4.52052wk Low
1.68%Amplitude
33.92%Gross Margin
90.41MMarket Cap
-3.31Reward/Risk
3.20%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

ImmuCell Corp's Score

-0.04vs previous score
Forecast--
Financial Health9.10
Technical2.83
Valuation Dimensions6.69
Institutional Confidence3.00
Risk Assessment4.38

Media Coverage

Coverage Level

Very Low
Very High
Neutral

ImmuCell Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Neutral

Moving Average

Neutral

ImmuCell Corp Latest Earnings Call Transcripts

ImmuCell (ICCC) Q2 2026 Earnings Call: Sales Rise 11.5%, Capacity Expansion Planned

ImmuCell Q2 2026 sales rose 11.5% to $7.2 million, while gross margin fell to 33.9%. Management detailed an $8 million capacity expansion plan.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.20/--
Revenue / Forecast
7.19M/--

ImmuCell Corp Profile

SectorPharmaceuticals
Ticker SymbolICCC
Number of employees69
CountryUnited States of America

Ownership

ShareholdersProportion
Knudsen (Ejnar A III)9.21%
Pessin (Norman H)7.12%
Rothschild (Jonathan E)5.68%
SRK Capital, LLC5.55%
Shareholder TypesProportion
Individual Investor32.15%
Investment Advisor14.56%
Investment Advisor/Hedge Fund3.82%
Hedge Fund2.10%

FAQs

What is the current price of ImmuCell Corp (ICCC)?

The current price of ImmuCell Corp (ICCC) is 9.99.

What is the symbol of ImmuCell Corp?

The ticker symbol of ImmuCell Corp is ICCC.

What is the 52-week high of ImmuCell Corp?

The 52-week high of ImmuCell Corp is 12.10.

What is the 52-week low of ImmuCell Corp?

The 52-week low of ImmuCell Corp is 4.52.

What is the market capitalization of ImmuCell Corp?

The market capitalization of ImmuCell Corp is 90.41M.

What is the Earnings Per Share (EPS TTM) of ImmuCell Corp (ICCC)?

The Earnings Per Share (EPS TTM) of ImmuCell Corp (ICCC) is -0.06.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.